Pay in 4 interest-free payments of $5.18 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Review common subcutaneous sites, rotation rules, and why injectable GHK-Cu is not FDA-approved for human use
BENEFITS/ CLINICAL TRIALS DSIP has been researched extensively
It is under investigation in preclinical and clinical studies on overweight, obesity, and metabolic disorders, where researchers have examined its effects on body weight and energy intake, including when combined with GLP 1 receptor agonists such as semaglutide, but it is not an approved therapy
CJC 1295, conversely, offers broader benefits
Non-medical usage, such as for immune boost, athletic preparation, or recovery, allows for personal choice in determining injection frequency, with some doctors suggesting a few vitamin B12 injections throughout the year
